Meta Pixel

News and Announcements

Announcing the One-Click Registration of Interest

  • Published February 04, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

After discussions between our investor relations team and the Wholesale Investor network worldwide, we have decided to make a subtle change to the ‘Register Interest’ journey between prospective investors and founders.

Previously, prospective investors have had to repeatedly fill out a 6 – field form every time they registered interest in an investment opportunity.

In an effort to make the process more convenient we have now implemented a one-click – register approach to all outgoing emails with the ‘register of interest’ button across all emails.

This means, all you have to do is click the button/link in the email and the information/request for further discussion will be passed on to the representatives of the investment opportunity being promoted. Also, there is still the option to update your details via the same form.

Please note, that some of you may have proactive and automatic security checks provided by your email provider, this could result in ‘registrations of interest’ being unintentional. Our analysis of this hurdle, to date, has shown that only a minority face this problem, and a technical solution is underway.

We are excited to see the results of improving the efficiency and convenience of this process, and look forward to continuing to work with our network and new technologies to help foster investor – founder communications more than ever.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now